Аннотация:
In the Russian Federation, a proportion of bladder cancer in the overall structure of malignant tumors is about 2.8[%] and among oncological diseases of genitourinary system its incidence is second only to prostate cancer. Bladder cancer ranks as ninth most prevalent in males and as eighteens in females. The most important issue is to determine a recurrence rate of non-muscle invasive bladder cancer, which can reach 80[%]. In this regard, currently, all over the world much more attention is paid to studying and creation of early detection, including non-invasive, which will be reliable in the early stages. It can possibly lead to a reduction the number of cystoscopy and become as "golden" standard of non-invasive diagnosis bladder cancer.
Glukhov A.I.
Polotdykova N.V.
Gordeev S.A.
Vinarov A.Z.
Polyakovsky K.A.
Rapoport L.M.
Tsarichenko D.G.
Enikeev D.V.
Glybochko P.V.
I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia, Moscow, Russia.
Department of Biochemistry of Sechenov First Moscow State Medical University of the Ministry of Health of Russia, Moscow, Russia.
M.V. Lomonosov Moscow State University, Faculty of Biology, Moscow, Russia.
University Clinical hospital 2 of I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia, Moscow, Russia.
Current trends in bladder cancer diagnosis
Текст визуальный электронный
Urologiia (Moscow, Russia : 1999)
№ 5 С. 100-105
2018
non-invasive diagnosis
telomerase
urinary bladder
urinary bladder cancer
Статья
Cystoscopy E01.370.388.250.180 E01.370.390.175 E04.502.250.180 E04.950.774.155
Цистоскопия E01.370.388.250.180 E01.370.390.175 E04.502.250.180 E04.950.774.155
Female
Женский
Humans B01.050.150.900.649.313.988.400.112.400.400
Человек B01.050.150.900.649.313.988.400.112.400.400
Male
Мужской
Neoplasm Recurrence, Local C04.697.655 C23.550.727.655
Новообразований рецидив местный C04.697.655 C23.550.727.655
Russia Z01.252.122.500 Z01.542.248.775
Российская Федерация Z01.252.122.500 Z01.542.248.775
Urinary Bladder Neoplasms C04.588.945.947.960 C12.050.351.937.820.945 C12.050.351.968.829.707 C12.200.758.820.968 C12.200.777.829.813 C12.900.820.945 C12.950.829.707 C12.950.983.945
Мочевого пузыря новообразования C04.588.945.947.960 C12.050.351.937.820.945 C12.050.351.968.829.707 C12.200.758.820.968 C12.200.777.829.813 C12.900.820.945 C12.950.829.707 C12.950.983.945
Journal Article V02.600
Журнальная статья V02.600
In the Russian Federation, a proportion of bladder cancer in the overall structure of malignant tumors is about 2.8[%] and among oncological diseases of genitourinary system its incidence is second only to prostate cancer. Bladder cancer ranks as ninth most prevalent in males and as eighteens in females. The most important issue is to determine a recurrence rate of non-muscle invasive bladder cancer, which can reach 80[%]. In this regard, currently, all over the world much more attention is paid to studying and creation of early detection, including non-invasive, which will be reliable in the early stages. It can possibly lead to a reduction the number of cystoscopy and become as "golden" standard of non-invasive diagnosis bladder cancer.